Vericel Corp: Form 10-K for the period ended Dec 31, 2012
Filed with the SEC on Mar 18, 2013 and accepted by EDGAR at Mar 18, 2013, 17:03 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2012-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2012-10-01 to 2012-12-31 | $19.0k | us-gaap:SalesRevenueNet |
| Revenue | 12 months2012-01-01 to 2012-12-31 | $21.0k | us-gaap:SalesRevenueNet |
| Cost of revenue | 12 months2012-01-01 to 2012-12-31 | $6.0k | us-gaap:CostOfGoodsSold |
| Research and development | 12 months2012-01-01 to 2012-12-31 | $26.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months2012-01-01 to 2012-12-31 | $7.8m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2012-10-01 to 2012-12-31 | −$7.6m | us-gaap:OperatingIncomeLoss |
| Operating income | 12 months2012-01-01 to 2012-12-31 | −$33.8m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2012-01-01 to 2012-12-31 | $12.0k | us-gaap:InterestExpense |
| Net income | 3 months2012-10-01 to 2012-12-31 | −$7.9m | us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic |
| Net income | 12 months2012-01-01 to 2012-12-31 | −$29.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2012-10-01 to 2012-12-31 | −$0.18 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 12 months2012-01-01 to 2012-12-31 | −$0.81 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 12 months2012-01-01 to 2012-12-31 | −$29.5m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 12 months2012-01-01 to 2012-12-31 | $273.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2012-12-31 | $13.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2012-12-31 | $14.0m | us-gaap:AssetsCurrent |
| Total assets | At period end2012-12-31 | $15.2m | us-gaap:Assets |
| Current liabilities | At period end2012-12-31 | $5.7m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2012-12-31 | $5.7m | us-gaap:Liabilities |
| Long-term debt | At period end2012-12-31 | $6.0k | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2012-12-31 | $34.0k | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2012-12-31 | −$32.1m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001104659-13-021790. Last ingested by Listed: Nov 14, 2026, 12:33 ET. Listed shows no prices and gives no investment advice.